Therapeutic window of opportunity in the acute uveitic phase of <scp>Vogt–Koyanagi–Harada</scp> disease: Prevention of late autoimmune complications by early intervention-Reference-Cited by-同舟云学术

Therapeutic window of opportunity in the acute uveitic phase of Vogt–Koyanagi–Harada disease: Prevention of late autoimmune complications by early intervention

Published:2022-09-21 Issue:2 Volume:101 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Abu El‐Asrar Ahmed M.¹²^ORCID,Al Rashed Faisal A.¹,AlBloushi Abdulrahman F.¹^ORCID,Tobaigy Mohannad F.¹,Gikandi Priscilla W.¹,Herbort Carl P.³,Opdenakker Ghislain¹⁴^ORCID

Affiliation:

1. Department of Ophthalmology; College of Medicine King Saud University Riyadh Saudi Arabia

2. Dr. Nasser Al‐Rashid Research Chair in Ophthalmology, College of Medicine King Saud University Riyadh Saudi Arabia

3. Department of Ophthalmology, Clinic Montchoisi Teaching Centre, Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS) University of Lausanne Lausanne Switzerland

4. Rega Institute for Medical Research, Department of Microbiology and Immunology and Transplantation, University of Leuven, KU Leuven, Leuven Belgium and University Hospitals UZ Gasthuisberg Leuven Belgium

Funder

King Saud University

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.15254

Reference29 articles.

1. Chronic Recurrent Vogt–Koyanagi–Harada Disease and Development of ‘Sunset Glow Fundus’ Predict Worse Retinal Sensitivity

2. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids

3. Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities